Rob Stein

Rob Stein is a correspondent and senior editor on NPR's science desk.

In his reporting, Stein focuses on the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, the obesity epidemic, and other science, medical, and health policy news.

Before NPR, Stein served as The Washington Post's science editor and national health reporter for 16 years, editing and then covering stories nationally and internationally.

Earlier in his career, Stein spent about four years at NPR's science desk. Before that, he served as a science reporter for United Press International in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts in Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Pages

Shots - Health News
9:13 pm
Wed April 30, 2014

Experimental Technique Coaxes Muscles Destroyed By War To Regrow

A cross-section of skeletal muscle in this light micrograph shows the individual, parallel muscle fibers (red). These fibers work in concert to power movement.
Thomas Deerinck, NCMIR ScienceSource

Originally published on Thu May 1, 2014 9:35 am

Ron Strang was on patrol in Afghanistan when a primitive land mine exploded.

"When it went off, it came across the front of my body," Strang says. Though he survived the blast, his left leg was never the same. Shrapnel destroyed most of the muscle on his left thigh. He used to run, swim and hike. But even after he recovered, those days of carefree movement were gone.

Read more
News
4:53 pm
Thu April 24, 2014

With New E-Cigarette Rules, FDA Hopes To Tame A 'Wild, Wild West'

Originally published on Thu April 24, 2014 7:17 pm

The Food and Drug Administration is proposing to expand its regulatory powers to e-cigarettes and other popular products containing nicotine.

Shots - Health News
12:03 am
Thu April 24, 2014

FDA Moves To Regulate Increasingly Popular E-Cigarettes

A woman tries electronic cigarettes at a store in Miami.
Joe Raedle Getty Images

Originally published on Thu April 24, 2014 3:33 pm

The Food and Drug Administration Thursday proposed regulating e-cigarettes for the first time.

The agency unveiled a long-awaited rule that would give it power to oversee the increasingly popular devices, much in the way that it regulates traditional cigarettes.

Read more
Shots - Health News
4:06 pm
Tue April 22, 2014

FDA Advisers Vote Against Approving New Opioid Painkiller

iStockphoto

Originally published on Tue April 22, 2014 9:50 pm

A key government panel Tuesday voted unanimously against approval of a powerful opioid prescription painkiller intended to provide faster relief with fewer side effects.

At the conclusion of a hearing, the Food and Drug Administration advisory committee voted 14-0 against recommending that the agency approve Moxduo, the first drug to combine morphine and oxycodone into one capsule.

Read more
Shots - Health News
3:29 am
Tue April 22, 2014

Powerful Narcotic Painkiller Up For FDA Approval

Morphine and oxycodone (the active ingredient in Oxycontin) are strong narcotic pain relievers on their own. Moxduo, a drug now up for FDA approval, would combine morphine and oxycodone in a single capsule.
Rich Pedroncelli AP

Originally published on Tue April 22, 2014 12:34 pm

The Food and Drug Administration is trying to decide whether to approve a powerful new prescription painkiller that's designed to relieve severe pain quickly, and with fewer side effects than other opioids.

While some pain experts say the medicine could provide a valuable alternative for some patients in intense pain, the drug (called Moxduo) is also prompting concern that it could exacerbate the epidemic of abuse of prescription painkillers and overdoses.

Read more

Pages